Findings could aid vax distribution in developing nations

Collaboration between drugmakers and other movers of cold chain products could help resolve difficulties in the distribution of vaccines and other healthcare products in infrastructure-poor developing nations. One example: Expanding established cold chains to the embassies located within a country.

That's one conclusion of a study conducted by supply chain consultancy Bisham on behalf of the World Health Organization and the nonprofit Program for Appropriate Technology in Health (PATH). Bisham compared health cold-chain logistics models with those of the food industry.

The consultancy finds that local third-party logistics providers (3PLs) need training and capital support from global 3PLs and drugmakers. Government health ministries also must step up in addressing the challenges, but they need "considerable advice, practical help and resources," says Derek Bell, managing director at Bisham, in a trade article.

PATH and WHO expect to begin implementing the recommendations in a phased program that begins this fall.

- here's the article

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.